Iontophoresis for Golfer’s Elbow: Clinical Protocol

by Service, Training and Support·November 11, 2025

ElbowIontophoresis

body{font-family:system-ui,-apple-system,Segoe UI,Roboto,Ubuntu,Cantarell,Noto Sans,sans-serif;line-height:1.6;margin:0;padding:32px;background:#fff;color:#111} h1,h2{color:#0f172a;margin-bottom:.4em} h1{font-size:clamp(1.6rem,2.2vw,2.2rem)} h2{font-size:clamp(1.2rem,1.9vw,1.6rem);margin-top:1.4em} h3{margin:.9em 0 .3em} ul,ol{margin:.5em 0 .9em 1.2em} table{width:100%;border-collapse:collapse;margin:1em 0;background:#fff;border:1px solid #e5e7eb} th,td{padding:10px 12px;border-bottom:1px solid #e5e7eb;vertical-align:top} th{background:#eef6ff;text-align:left} .card{background:#f8fafc;border:1px solid #e5e7eb;border-radius:12px;padding:14px;margin:.8em 0} .tiny{font-size:.9rem;color:#475569} footer{margin-top:24px;font-size:.9rem;color:#475569}

Golfer’s elbow, traditionally called medial epicondylitis, is pain arising from the common flexor-pronator tendon near the inside of the elbow. It is associated with repetitive or excessive gripping, wrist flexion, forearm pronation, throwing, lifting, and tool use.

The newer term "medial elbow tendinopathy" is often more anatomically accurate. Persistent cases commonly involve tendon disorganization and degeneration rather than a purely inflammatory process. The condition can affect golfers, but it is also seen in throwing athletes, racquet-sport participants, tradespeople, healthcare workers, weightlifters, and anyone whose work or recreation repeatedly loads the wrist flexors and forearm pronators.

Iontophoresis may be considered when:

Symptoms are localized near the common flexor-pronator origin.
The diagnosis has been reasonably confirmed.
The skin is intact.
A prescriber has selected an appropriate ionized medication.
Medication polarity has been verified.
The patient is suitable for direct-current treatment.
Short-term symptom control has a defined rehabilitation purpose.
Progress will be measured objectively.

Iontophoresis should be positioned as a clinician-directed medication-delivery adjunct, not as a cure, tendon-repair procedure, or proven replacement for injection.

For general medication, polarity, filling, dose limit, and device instructions, use Balego’s Iontophoresis Electrode Directions for Use. This protocol concentrates on the medial elbow rather than repeating that material.

Clinical scope: This guide is intended for licensed healthcare professionals. It does not prescribe medication, concentration, polarity, current, electrical dose, treatment frequency, or total number of applications.

Medial epicondylitis medication and return electrode placement

Golfer’s Elbow Iontophoresis: Quick Clinical Summary

Clinical question	Practical answer
What tissue is usually involved?	The common flexor-pronator tendon at or just distal to the medial epicondyle
Which muscles contribute to the tendon?	Pronator teres, flexor carpi radialis, palmaris longus, flexor digitorum superficialis, and flexor carpi ulnaris
What commonly reproduces symptoms?	Resisted wrist flexion, forearm pronation, gripping, and passive wrist-extension stretch
Where is the medication electrode positioned?	Over the most tender portion of the common flexor-pronator origin
What nearby structure requires special attention?	The ulnar nerve behind the medial epicondyle
Should the drug electrode cover the cubital tunnel?	Generally no; avoid placing concentrated current directly over the symptomatic ulnar nerve
Where does the return electrode go?	Over intact nearby muscle tissue according to the electrode-system instructions
Is 40 mA·min always required?	No, it is a frequently studied dose, not a universal prescription
Is six treatments the standard course?	No; six treatments came from an older combined medial/lateral epicondylitis trial
What should accompany treatment?	Load modification, progressive tendon loading, grip rehabilitation, proximal strengthening, and activity retraining
When is referral important?	Trauma, instability, neurological symptoms, youth throwing injury, marked weakness, or failure to improve

Medial Elbow Anatomy and Why It Matters

The medial epicondyle is the bony prominence on the inside of the elbow. The common flexor tendon attaches in this region and connects several muscles responsible for wrist flexion, finger flexion, and forearm pronation.

Muscle	Principal contribution relevant to golfer’s elbow
Pronator teres	Turns the palm downward and assists elbow flexion
Flexor carpi radialis	Flexes the wrist and moves it toward the thumb side
Palmaris longus	Assists wrist flexion when present
Flexor digitorum superficialis	Flexes the fingers and contributes to forceful gripping
Flexor carpi ulnaris	Flexes the wrist and moves it toward the little-finger side

In medial epicondylitis, clinicians frequently emphasize the pronator teres and flexor carpi radialis, although symptoms may also involve the broader flexor-pronator origin.

The ulnar nerve is immediately nearby

The ulnar nerve passes behind the medial epicondyle through the cubital-tunnel region. This creates two important clinical implications:

Medial epicondylitis may coexist with ulnar-nerve irritation.
Not every case of medial elbow pain is a tendon disorder.

Numbness, tingling, burning, or altered sensation in the ring and little fingers should prompt a more complete ulnar-nerve assessment. Weakness or wasting of ulnar-innervated hand muscles requires medical evaluation rather than simply repositioning an iontophoresis electrode.

Typical Golfer’s Elbow Symptoms

Common features include:

Gradual pain at the inside of the elbow
Tenderness over or just below the medial epicondyle
Pain during forceful gripping
Pain with wrist flexion
Pain with forearm pronation
Reduced grip tolerance
Pain when lifting with the palm up
Symptoms during golf, throwing, climbing, weightlifting, or tool use
Stiffness after activity
Difficulty opening containers or carrying objects

Common Causes and Loading Patterns

Golfer’s elbow generally reflects repeated tendon loading that exceeds current tissue capacity.

Loading pattern	Examples
Repeated gripping	Tools, weights, climbing holds, racquets, golf clubs
Wrist flexion under load	Lifting, curls, manual work, repetitive pulling
Repeated pronation	Screwdriver use, throwing, racquet or bat movement
High-force finger flexion	Carrying, gripping handles, occupational pinch and grasp
Throwing stress	Baseball, softball, javelin, football
Sudden training increase	More repetitions, heavier weights, increased practice volume
Poor technique	Late golf impact, excessive wrist action, throwing-mechanics errors
Equipment mismatch	Incorrect grip size, heavy tool, unsuitable racquet or club
Insufficient recovery	Repeated loading without adequate adaptation
Direct trauma	Impact to the medial elbow or acute flexor-pronator strain

A treatment plan should identify the provoking load rather than focusing only on where the elbow hurts.

What Does the Evidence Say About Iontophoresis?

The principal epicondylitis trial

A randomized, double-blinded, placebo-controlled study evaluated dexamethasone sodium phosphate iontophoresis in 199 patients with acute medial or lateral epicondylitis.

The research protocol used:

Symptoms generally lasting three months or less
Six treatments
Treatments spaced one to three days apart
Completion within 15 days
A 40 mA·min electrical dose
Dexamethasone sodium phosphate 0.4% or saline placebo

At two-day follow-up, the dexamethasone group had greater pain improvement and more favorable investigator ratings. At one month, differences between active and placebo groups were not statistically significant for the principal outcomes. The researchers therefore supported short-term symptom reduction—not a durable or medial-elbow-specific superiority claim.

Important limitations

Limitation	Why it matters
Medial and lateral cases were pooled	The study did not establish a separate medial-epicondylitis effect size
Participants had relatively acute symptoms	Results may not transfer to long-standing degenerative tendinopathy
The benefit was strongest shortly after treatment	The advantage was not statistically significant at one month
One medication and concentration were studied	The findings do not validate every medication formulation
The product workflow was controller-based.	Results cannot automatically be transferred to every wearable patch
Electrode-site reactions were common	Skin monitoring remains essential
The study had commercial product funding	Funding context should be disclosed when interpreting results

The trial also stated that the ideal number and spacing of iontophoresis treatments had historically been based more on clinical experience than robust comparative research.

Responsible evidence statement

Iontophoresis may help reduce symptoms over the short term in selected patients with acute epicondylitis. Current evidence does not establish it as

A stand-alone tendon-healing treatment
Superior to progressive rehabilitation
Equivalent to injection
Proven specifically for chronic medial epicondylitis
A guaranteed way to prevent surgery
Appropriate for every source of medial elbow pain

Evaluate the Patient Before Treating the Elbow

Subjective history

Question	Why it matters
Where is the pain located?	Distinguishes common flexor origin from cubital tunnel, UCL, joint, or referred pain
How did it begin?	Separates gradual overload from acute strain, fracture, or ligament injury
Which movements provoke it?	Identifies grip, flexion, pronation, throwing, lifting, or occupational load
Is pain present during or after activity?	Helps assess irritability and load response
Is there numbness or tingling?	Screens for ulnar neuropathy
Is the elbow unstable, or does it “give way”?	Raises concern for ligament injury
Was there a pop, sudden pull, or bruising?	May indicate acute tendon or ligament damage
Is the patient a throwing athlete?	Requires attention to valgus load and the UCL
Is the patient skeletally immature?	Medial epicondyle apophysitis or avulsion may mimic golfer’s elbow
What work or sport must be resumed?	Defines functional goals and return criteria
What treatments have already been tried?	Prevents indefinite repetition of ineffective care
Which medications and allergies are present?	Required before iontophoresis
Is there skin or adhesive sensitivity?	Affects electrode or patch selection

Observation

Assess:

Swelling
Bruising
Redness or warmth
Skin integrity
Surgical scars
Carrying angle
Protective arm posture
Forearm-muscle asymmetry
Elbow extension during functional use
Throwing or lifting mechanics when relevant

Palpation

Palpate systematically:

Medial epicondyle
Common flexor-pronator tendon
Pronator teres origin
Flexor carpi radialis region
Ulnar nerve and cubital tunnel
Ulnar collateral ligament
Medial joint line
Olecranon
Distal biceps and brachialis when indicated

The medication target should be the reproducible tendon pain—not simply the most prominent bone.

Range of motion

Measure:

Elbow flexion and extension
Forearm pronation and supination
Wrist flexion and extension
Radial and ulnar deviation when relevant
Cervical and shoulder movement if symptoms suggest a regional contribution

Limited motion is not always a defining feature of golfer’s elbow. Marked joint restriction should prompt consideration of arthritis, trauma, effusion, or another elbow disorder.

Strength and function

Assess according to symptom irritability:

Wrist flexion strength
Forearm pronation strength
Pain-free grip strength
Finger-flexion tolerance
Elbow flexion and extension
Shoulder and scapular strength
Lifting tolerance
Carrying tolerance
Work-tool use
Golf, racquet, climbing, or throwing tasks

Pain-free grip strength is often more useful than maximal grip because it records the force tolerated before symptoms appear.

Provocation Tests

No single test should be treated as diagnostic in isolation.

Test	Basic method	Positive response
Resisted wrist flexion	Elbow supported while the patient flexes the wrist against resistance	Familiar pain at the common flexor origin
Resisted forearm pronation	Patient turns the palm downward against resistance	Familiar medial epicondyle or proximal forearm pain
Combined flexion-pronation test	Wrist flexion and pronation resisted together	Reproduction of localized tendon symptoms
Passive wrist-extension stretch	Elbow extended with the forearm supinated and wrist/fingers extended	Stretch pain at the flexor-pronator origin
Grip test	Grip dynamometer or functional object	Medial elbow pain or reduced pain-free grip
Tinel test at cubital tunnel	Gentle percussion over the ulnar nerve	Tingling into the ring or little finger
Valgus-stress testing	Performed when ligament injury is suspected	Medial pain, laxity, or apprehension requiring further assessment

The diagnosis is supported by localized tenderness and pain reproduced with resisted wrist flexion or pronation. A comprehensive examination remains necessary because the medial elbow contains the common flexor tendon, UCL, ulnar nerve, joint structures, and medial epicondyle within a small region.

Differential Diagnosis of Medial Elbow Pain

Possible condition	Findings that may distinguish it
Ulnar neuropathy or cubital-tunnel syndrome	Tingling or numbness in the ring and little fingers, hand weakness, symptoms with sustained elbow flexion
Ulnar collateral ligament injury	Throwing history, valgus pain, instability, reduced throwing velocity
Flexor-pronator strain or tear	Acute onset, bruising, weakness, pain after a specific forceful event
Medial epicondyle apophysitis	Skeletally immature throwing athlete with medial-elbow pain
Medial epicondyle avulsion fracture	Acute trauma or throwing injury, swelling, marked tenderness, loss of function
Elbow osteoarthritis	Joint-line pain, stiffness, reduced range, mechanical symptoms
Cervical radiculopathy	Neck symptoms, radiating pain, reflex or sensory changes
Pronator syndrome	Median-nerve symptoms with proximal forearm pain
Ulnar-nerve instability	Snapping or subluxation behind the medial epicondyle
Snapping triceps	Medial snapping during elbow movement
Inflammatory or infectious condition	Marked warmth, redness, swelling, fever, or systemic illness
Referred shoulder or wrist pain	Symptoms reproduced outside the local elbow examination

Ultrasound or MRI may be useful when the diagnosis is uncertain, a tear or ligament injury is suspected, symptoms are atypical, or conservative care is unsuccessful. Medial elbow ultrasound must differentiate tendon pathology from ulnar-nerve instability, UCL injury, snapping triceps, and joint disease.

Red Flags and Referral Criteria

Refer for medical evaluation before iontophoresis when there is:

Acute trauma with a pop or sudden loss of strength
Marked swelling or bruising
Suspected tendon tear
Valgus instability
Suspected UCL injury
Numbness, tingling, or progressive hand weakness
Muscle wasting
Inability to grip or use the arm normally
Loss of elbow motion after trauma
Fever, redness, drainage, or suspected infection
Severe night or resting pain
A palpable mass
Symptoms in a child or adolescent throwing athlete
Possible medial epicondyle apophyseal or avulsion injury
An implanted device or medical condition prohibited by the iontophoresis labeling
Uncertainty about the prescribed medication or polarity

Little League elbow and medial epicondyle avulsion injuries should not be treated as adult golfer’s elbow. Skeletally immature athletes require a separate diagnostic and treatment pathway.

When Iontophoresis May Fit

A clinician may consider iontophoresis when:

Pain is localized to the superficial common flexor-pronator origin.
Symptoms are mild to moderate.
The presentation is nontraumatic.
Neurologic symptoms are absent or separately evaluated.
The elbow is stable.
A prescriber has ordered an appropriate medication.
The exact formulation and polarity are known.
The skin is intact.
An electrode can fit without covering or compressing the cubital tunnel.
Symptoms limit participation in a progressive loading program.
A defined reassessment point has been established.

When another approach may be more appropriate

Finding	Clinical response
Predominant ring- or little-finger tingling	Evaluate the ulnar nerve
Throwing-related instability	Evaluate the UCL and throwing mechanics
Acute weakness or bruising	Rule out flexor-pronator tear
Child or adolescent athlete	Rule out apophyseal injury
Diffuse joint pain and stiffness	Assess intra-articular pathology
Skin breakdown near the target	Do not place the electrode over the area
No response to a defined trial	Reconsider diagnosis and treatment strategy
Longstanding degenerative symptoms	Emphasize progressive loading rather than repeated passive treatment
Inability to fit the patch safely	Select a smaller controller-based electrode or another treatment

Golfer’s Elbow Iontophoresis Protocol Framework

Step 1: Confirm the medical order

Before opening an electrode or patch, verify:

Medication name
Exact chemical formulation
Concentration
Prescribed volume
Ionic charge
Required polarity
Electrical dose
Maximum current
Treatment frequency
Planned number of applications
Medication allergies
Treatment location

Medication is supplied separately from Balego’s iontophoresis controllers, electrodes, and wearable patches.

Use the Iontophoresis FAQ, Medication, Dose, and Polarity Guides when clarification is needed, but confirm the exact order with the prescriber or pharmacist.

Step 2: Record baseline outcomes

Useful measures include:

Outcome	Baseline method
Pain at rest	0–10 rating
Pain with gripping	0–10 rating during a standardized grip
Pain-free grip	Dynamometer or repeatable functional task
Wrist-flexion tolerance	Resistance level before familiar pain
Pronation tolerance	Resistance level before familiar pain
Local tenderness	Standardized palpation site
Function	QuickDASH, Patient-Specific Functional Scale, or clinic-selected measure
Work tolerance	Time, repetitions, weight, or task duration
Sport tolerance	Swings, throws, climbs, or lifts before symptom increase
Neurologic status	Sensation and ulnar-nerve findings
Skin condition	Document both planned electrode sites

Step 3: Identify and mark the tendon target

Locate the most reproducible tender point at the common flexor-pronator origin.

The target is typically:

At or slightly distal and anterior to the medial epicondyle
Within the common flexor-pronator tendon region
Reproduced by resisted wrist flexion or pronation
Separate from the ulnar-nerve groove behind the medial epicondyle

Mark the site before skin preparation.

Step 4: Choose an electrode system that fits the elbow

Consider:

Size of the tender region
Elbow contour
Medication volume
Prescribed dose
Need for current adjustment
Skin sensitivity
Adhesive tolerance
Patient schedule
Whether the elbow will move repeatedly
Proximity to the ulnar nerve
Need for direct clinical observation

A flexible or butterfly-shaped controller electrode may conform better to the curved medial elbow than a large flat patch.

Step 5: Prepare the skin according to the product

Do not use one skin-preparation rule for every iontophoresis system.

Some controller-electrode kits include alcohol preparation pads.
Wearable patches may specify soap-and-water preparation.
The selected controller, electrode, and patch instructions remain controlling.

General principles include:

Use intact skin.
Remove lotion, oil, and heavy contamination.
Allow the site to dry fully.
Clip excessive hair when necessary.
Do not shave immediately before treatment.
Avoid abrasions, eczema, wounds, recent injections, and irritated skin.
Inspect both the medication and return-electrode sites.

Review Iontophoresis Electrode Directions for Use for product-specific setup rather than duplicating those instructions here.

Step 6: Position the medication electrode

Place the active drug electrode.

Over the marked common flexor-pronator tendon target
Anterior or slightly distal to the medial epicondyle when that corresponds with the examination
With the entire conductive surface in contact
Away from damaged skin
Away from the posterior ulnar-nerve groove
Without wrinkles, lifted edges, or fluid leakage
Without tight wrapping or external compression

Avoid placing the reservoir.

Directly over a symptomatic ulnar nerve
In the cubital-tunnel groove
Over the tip of the medial epicondyle when the electrode cannot lie flat
Where elbow flexion repeatedly folds the electrode
Beneath a tight brace or counterforce strap
Where the patient will lean on it

Step 7: Position the return electrode

The return electrode should be placed on intact soft tissue according to the selected system’s instructions.

Potential sites include:

Proximal forearm muscle mass
Distal upper-arm muscle
Biceps region
Triceps region

Placement consideration	Clinical purpose
Adequate distance from the drug electrode	Supports the intended current path
Full contact over soft tissue	Helps distribute current
Avoid prominent bones.	Reduces concentrated pressure and poor adhesion
Avoid crossing the cubital tunnel unnecessarily	Prevents direct treatment of a potentially irritable nerve
Follow product spacing instructions	Different electrode kits have different requirements

Ionto4’s instructions, for example, specify placing the return electrode over a major muscle approximately four to six inches from the active electrode. Other systems may differ.

Step 8: Support the arm and minimize movement

Position the patient with:

The shoulder relaxed
The elbow comfortably supported
The forearm supported in a position that exposes the medial tendon
Lead wires given enough slack
No pressure beneath either electrode

The current page instructs the patient to flex and extend the arm during treatment. That should be removed. Repeated elbow movement can lift electrodes, tug lead wires, alter contact, and increase treatment interruption.

Movement and exercise belong in the rehabilitation portion of the visit—not during active controller-based drug delivery unless the specific product and clinician protocol expressly allow it.

Step 9: Deliver the prescribed treatment

Controller-based iontophoresis

With the ActivaDose II Iontophoresis Controller:

Connect the drug and return electrodes using the verified polarity.
Select the prescribed dose.
Select a tolerable current within the controller and electrode limits.
Begin treatment using the controller’s ramping function.
Monitor the displayed current, remaining dose, and treatment time.
Reduce current if the patient reports excessive stinging or discomfort.
Stop for burning, sharp pain, repeated electrode-reject alerts, or loss of contact.
Allow automatic ramp-down at treatment completion.

ActivaDose II permits selection from 0–80 mA·min and current adjustment up to 4 mA. The controller calculates and recalculates treatment time from the selected current and dose.

Wearable iontophoresis patch

With a self-contained patch:

Confirm the model and labeled dose capacity.
Identify the correct medication chamber.
Apply only the directed medication volume.
Complete any required activation step.
Position the medication reservoir over the marked tendon region.
Ensure the patch does not cover or compress the cubital tunnel.
Secure the border without forcing liquid toward the adhesive.
Record the application and planned removal time.
Give written skin, activity, and removal instructions.
Do not extend wear because symptoms remain.

Step 10: Inspect and document the skin

After treatment:

Reduce controller output to zero when applicable.
Remove the electrode or patch according to its instructions.
Inspect both sites.
Document redness, itching, burning, blistering, or adhesive reaction.
Note whether a reaction occurred beneath the medication or return electrode.
Do not repeat treatment over irritated skin.
Report a suspected medication reaction.

The 2003 epicondylitis trial observed frequent electrode-site reactions in both active and placebo groups, although most were described as mild. Skin monitoring is therefore not optional.

Historical Research Schedule vs. Individual Clinical Plan

Treatment element	2003 epicondylitis trial	Current interpretation
Diagnosis	Acute medial or lateral epicondylitis	Do not assume the result applies equally to chronic medial tendinopathy
Medication	Dexamethasone sodium phosphate 0.4%	Medication and formulation must come from the current prescriber
Electrical dose	40 mA·min	Common evidence-based reference, not a universal requirement
Treatments	Six	Do not prescribe six automatically
Spacing	One to three days apart	The schedule should reflect order, skin tolerance, and response
Treatment window	Completed within 15 days	Historical study design, not a mandatory rule
Main benefit	Short-term symptom improvement	Use iontophoresis to support active rehabilitation
One-month result	No statistically significant principal difference	Do not promise lasting benefit from the modality alone

Comparing Iontophoresis Options for the Medial Elbow

The complete product specifications remain on the linked product pages. This table concentrates on medial-elbow fit and workflow.

Balego option	Format	Medial-elbow advantage	Important consideration
ActivaDose II Controller with Trivarion	Wired, clinician-controlled	Direct current and dose control with flexible, form-fitting electrodes	Requires in-clinic connection and monitoring
Trivarion Delivery Kits	Flexible controller electrode	Designed to conform to curved or uneven areas such as the elbow	Select the size that avoids the ulnar-nerve groove
Ionto4 Electrode Kits	Controller-based square or butterfly electrode	Four footprint and fill-volume options	A square electrode may not conform as well as a butterfly shape
Buffered Iontophoresis Electrode Kits	Controller-based Ag/AgCl electrode system	Buffered return electrode and multiple sizes	Must be paired with a compatible controller
IontoPATCH	Self-contained wearable patch	No external controller; 80- and 120-mA·min options	Patch movement and cubital-tunnel proximity must be evaluated
ACTIVApatch	Self-contained no-saline wearable patch	Treatment windows from about 1.25 to 12 hours	Elbow flexion can challenge adhesion and reservoir placement

Best fit by workflow

Clinical priority	Product format to consider
First application with direct observation	ActivaDose II with a controller electrode
Small, localized tendon target	Small Trivarion or small Ionto4
Curved medial-elbow anatomy	Trivarion or butterfly electrode
Exact current adjustment	ActivaDose II
Need to lower current while maintaining dose	ActivaDose II
Short wearable 40 mA·min option	ACTIVApatch IntelliDose 2.5
Wearable 80 mA·min treatment	IontoPatch or ACTIVApatch, depending on desired wear profile
Higher 120 mA·min patch capacity	IontoPatch Extra Strength, when specifically directed
Sensitive skin or uncertain tolerance	Begin with direct clinician monitoring rather than assuming a patch will be better

Trivarion is available in 1.5, 2.0, and 3.5 cc configurations and is specifically designed to conform to curved or irregular treatment regions. Ionto4 and Balego’s buffered electrodes offer small, medium, large, and butterfly choices.

Iontophoresis Compared with Other Golfer’s Elbow Treatments

Treatment	Primary role	Main advantage	Important limitation
Load modification	Reduces repeated tendon overload	Addresses a principal aggravating factor	Must be paired with gradual rebuilding
Progressive exercise	Restores tendon and muscle capacity	Targets long-term function	Requires appropriate dosage and adherence
Flexor-pronator stretching	Maintains mobility and load tolerance	Simple home-program component	Aggressive stretching may irritate acute symptoms
Counterforce strap	Temporarily changes forearm-tendon loading	May help selected activities	Can irritate the ulnar nerve if positioned poorly
Wrist support	Reduces repeated wrist-flexor demand	Useful during selected tasks or rest periods	Prolonged dependence may limit recovery
Topical or oral medication	Short-term symptom management	Accessible when medically appropriate	Does not rebuild tendon capacity
Iontophoresis	Localized medication delivery	Noninvasive and adjustable with a controller	Evidence is principally short-term.
Corticosteroid injection	Procedural anti-inflammatory treatment	May provide short-term relief	Tissue effects, recurrence, and diagnosis must be considered
Shockwave or other procedures	Option for selected persistent cases	Nonoperative	Evidence and protocols vary
Surgery	Debridement or repair in refractory cases	Addresses persistent structural pathology	Operative risk and rehabilitation

Most medial epicondylitis cases are initially managed conservatively. Exercise, activity modification, and progressive loading should remain central even when a passive modality is used.

Iontophoresis avoids a needle puncture, but it should not be called risk-free or equivalent to an injection. It introduces its own limitations, including skin irritation, variable transdermal delivery, electrode fit, and dependence on the exact medication formulation.

Rehabilitation That Should Accompany Iontophoresis

AAOS recommends stretching and strengthening the muscles attached to the affected tendon to support recovery and improve resistance to repetitive stress.

Stage 1: Reduce irritability

Goals:

Identify and reduce the principal aggravating load.
Maintain comfortable elbow and wrist motion.
Begin pain-limited isometric loading.
Preserve grip without repeatedly provoking symptoms.
Address workstation, tool, sport, or lifting technique.

Potential activities:

Isometric wrist flexion
Isometric pronation
Gentle pain-free grip
Comfortable wrist-flexor stretch
Shoulder and scapular control
Modification of handle or grip size

Stage 2: Rebuild tendon capacity

Progress gradually to:

Concentric and eccentric wrist flexion
Resisted forearm pronation
Flexor carpi radialis and ulnaris loading
Grip endurance
Finger-flexor loading
Elbow and shoulder strengthening
Carrying and lifting patterns
Controlled sport- or work-specific tasks

Our resistance bands and tubing can support progressive clinician-directed strengthening.

Stage 3: Restore occupational or sport demands

Progress toward:

Repeated gripping
Heavier lifting and carrying
Golf-club or racquet control
Throwing preparation
Tool and work simulation
Pulling and climbing tasks
Higher-speed forearm rotation
Fatigue-resistant grip

Return should be based on symptoms, strength, load tolerance, and movement quality—not simply the completion of an iontophoresis series.

Technique and equipment review

Consider:

Golf grip size and swing mechanics
Racquet grip and string tension
Throwing volume and mechanics
Tool-handle diameter
Use of vibration-producing tools
Wrist position during lifting
Repetition and rest scheduling
Shoulder and trunk contribution

Reassessment and Stopping Rules

Recommended outcome measures

Outcome	Baseline	Meaningful change
Pain with standardized grip	0–10 rating	Lower pain during the same task
Pain-free grip force	Dynamometer or repeatable object	More force before symptoms
Resisted wrist flexion	Pain and resistance tolerated	Less pain or greater tolerated load
Resisted pronation	Pain and resistance tolerated	Less pain or greater tolerated load
Palpation tenderness	Standardized tendon location	Reduced sensitivity
QuickDASH or PSFS	Validated questionnaire score	Improved function
Work tolerance	Weight, time, or repetitions	Greater capacity
Sport tolerance	Swings, throws, climbs, or lifts	Greater symptom-free volume
Ulnar-nerve symptoms	Sensory and motor findings	No new or worsening neurologic signs
Skin response	Inspection after every treatment	No accumulating irritation

Continue only when:

The skin remains suitable.
The medication remains appropriate.
Pain or function is improving.
The patient is progressing with active rehabilitation.
Iontophoresis is serving a defined functional objective.
The treatment is not delaying needed diagnostic evaluation.

Modify or discontinue when:

Burning, blistering, or persistent redness develops.
The patch or electrode repeatedly lifts.
The electrode cannot avoid the ulnar-nerve region.
Pain worsens.
Neurologic symptoms appear.
Instability becomes evident.
No measurable functional improvement occurs.
Benefit lasts only briefly without progress in load tolerance.
Treatment replaces rather than supports exercise.
The diagnosis becomes uncertain.

Repeating the same passive treatment without improved grip, lifting, work, or sport tolerance is not a complete rehabilitation strategy.

Frequently Asked Questions

Can iontophoresis cure golfer’s elbow?

No. It may support short-term symptom reduction by delivering a prescribed ionic medication through intact skin. It does not directly reorganize tendon collagen or restore tendon strength.

Is iontophoresis proven specifically for medial epicondylitis?

Evidence is limited. The best-known randomized trial included both medial and lateral epicondylitis and did not publish a separate medial-only treatment effect.

Is iontophoresis a replacement for corticosteroid injection?

No. It is a different medication-delivery approach with different evidence, risks, dose characteristics, and limitations.

Where is the medication electrode placed?

It is generally centered over the most tender portion of the common flexor-pronator tendon at or just distal and anterior to the medial epicondyle.

Should the electrode cover the ulnar nerve?

Avoid placing concentrated current directly over the posterior ulnar-nerve groove, particularly when the patient has tingling, numbness, or cubital-tunnel symptoms.

Where should the return electrode be placed?

Place it on intact nearby muscle tissue according to the selected electrode instructions. Potential regions include the proximal forearm, biceps, or triceps.

Is 40 mA·min the standard golfer’s-elbow dose?

It is a commonly cited research dose, but it is not mandatory for every patient. Follow the medication order and the controller and electrode limits.

Are six treatments required?

No. Six treatments were used in a historical trial. The treating professional should establish the course and reassessment point.

Should the elbow move during controller treatment?

Generally, the elbow should remain comfortably supported to preserve electrode contact. Exercise can be completed before or after treatment as directed.

Can a wearable patch be used on the medial elbow?

Yes, when the reservoir can remain over the target without folding, lifting, compressing the cubital tunnel, or being displaced by elbow movement.

Is a flexible controller electrode better than a patch?

It may be preferable when the target is small, the elbow contour is difficult, direct monitoring is needed, or a large patch would overlap the ulnar-nerve region.

Can a counterforce strap be worn over the patch?

Do not compress an active patch or electrode beneath a tight strap. Strap use should follow the clinician’s instructions and occur separately when necessary.

What if the patient has ring- and little-finger tingling?

Evaluate for ulnar-nerve involvement. Do not assume the symptoms are caused only by golfer’s elbow.

Can iontophoresis be used for a young baseball pitcher?

Medial elbow pain in a skeletally immature athlete may involve the growth plate or an avulsion injury. Obtain an appropriate medical evaluation before treating it as adult medial epicondylitis.

When should a specialist be consulted?

Referral is appropriate for trauma, suspected tear, instability, neurologic deficits, youth throwing injury, substantial weakness, uncertain diagnosis, or symptoms that do not improve with a properly followed conservative plan.

Additional Related Resources

This protocol is intended for professional education. Prescription-medication iontophoresis should be performed only under appropriate medical direction and according to the medication labeling, controller instructions, electrode or patch instructions, facility policy, and applicable scope-of-practice requirements.

Back to Article Category